United States · 
What does RiverVest invest in?
RiverVest invests most often at Series A and Series B (51% of the rounds on record), in sectors such as Life Sciences, Biotechnology and Therapeutics.
RiverVest highlights
- 01
39 rounds on record
- 02
Mostly Series A and Series B: 51% of its rounds
- 03
Sole investor in 3 rounds, median $18M
- 04
8 exits from the portfolio
What they do
RiverVest is a leading venture capital firm building life science companiesFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $10M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Life SciencesBiotechnologyTherapeutics
- Based in
- Saint Louis, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first39 appearances
- 2021
1 round
- Jun
- 2019
4 rounds
- Jun
- May
- Apr
- Mar
- 2017
2 rounds
- Aug
- May
- 2016
1 round
- Aug
- 2015
1 round
- Nov
- 2014
7 rounds
- Sept
- Sept
- Aug
- Apr
- Mar
- Mar
- Mar
- 2013
4 rounds
- Oct
- Sept
- May
- Jan
- 2012
3 rounds
- Dec
- Oct
- Oct
- 2011
1 round
- Aug
- 2010
6 rounds
- Oct
- Sept
- Sept
- Aug
- Jan
- Jan
- 2008
1 round
- Feb
- 2007
3 rounds
- Nov
- Jun
- Jan
- 2006
1 round
- May
- 2004
2 rounds
- Sept
- Jan
- 2003
2 rounds
- Oct
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration7 named
AWAnthony W. ArnerichMember of 3x5 Partners Managers II, LLC.iFiling they signed
JWJay William SchmelterManager of the general partner of the General Partner.iFiling they signed
JPJohn Patrick MckearnManager of the general partner of the General Partner.iFiling they signed
KPKaren P. SpilizewskiOfficer of the General Partner.iFiling they signed
NANiall Anthony O'DonnellManager of the general partner of the General Partner.iFiling they signed
NWNicholas W. WalrodMember of 3x5 Partners Managers II, LLC.iFiling they signed
TCThomas Clifford MelzerManager of the General Partner of the Sole Member.iFiling they signed
We also hold 27 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$433Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Rivervest Venture Management LLC
- SEC number
- CRD 160239
What they claim to have backed
From their own portfolio page (on their website)
1 of 4 we have independently watched raise
BehanceRiverVest Fund IVStatcounterTransparency-in-coverage
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed8 in all
ZS PharmaBought by AstraZeneca$2.7BNov 2015
Lumena PharmaceuticalsBought by Shire$260MMay 2014
AccumetricsBought by ITCUndisclosedAug 2013
IDEV TechnologiesBought by Abbott Labs$310MJul 2013
Excaliard PharmaceuticalsBought by Excaliard PharmaceuticalsUndisclosedNov 2011
Calypso MedicalBought by Varian Medical SystemsUndisclosedSept 2011
Salient Surgical TechnologiesBought by Medtronic$525MJul 2011
VelocimedBought by St. Jude Medical$74MFeb 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.